Cnbx Pharmaceuticals Inc.
CNBX
Revenue
0.00
▼-40.64k▼-100.00%
3 Months ChangeAssets
80.03k
▼-83.89k▼-51.18%
3 Months ChangeLiabilities
586.21k
▼-183.30k▼-23.82%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-07-15
Form 10-Q
ID: 0001683168-24-004831
2024-04-16
Form 10-Q
ID: 0001683168-24-002440
2024-03-22
Form 8-K
ID: 0001683168-24-001610
2024-01-12
Form 10-Q
ID: 0001683168-24-000255
2023-07-14
Form 10-Q
ID: 0001683168-23-004890
2023-04-14
Form 10-Q
ID: 0001683168-23-002379
2023-02-08
Form 8-K
ID: 0001683168-23-000628
2023-01-13
Form 10-Q
ID: 0001683168-23-000174
2022-12-29
Form 8-K
ID: 0001683168-22-008672
2022-07-25
Form 8-K
ID: 0001683168-22-005100